WHO ICTRP trial
Monitoring Side Effects of Tuberculosis and HIV Medications: Understanding side…
CTRI/2024/07/069753 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/07/069753 |
|---|---|
| Public title | Monitoring Side Effects of Tuberculosis and HIV Medications: Understanding side effects in Patients on ATT and ART for Better Treatment |
| Scientific title | Adverse Drug Reaction monitoring in Patients receiving Anti Tubercular ( ATT ) and Antiretroviral Therapy ( ART ) - NIL |
| Primary sponsor | Dr Puneet Paliwal |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: B20- Human immunodeficiency virus [HIV]disease Health Condition 2: A150- Tuberculosis of lung |
| Interventions | Control Intervention1: nil: nil |
| Registration date | Jan 7, 2024 |
| Target size | 600 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: